New eczema pill shows promise in early trial
Symptom relief
Recruiting now
This study tests an oral medication called roflumilast for people aged 12 and older with moderate-to-severe atopic dermatitis (eczema). Over 12 weeks, 36 participants will take a daily pill to see if it reduces skin symptoms like itching and rash. The goal is to find a new treatm…
Phase: PHASE2 • Sponsor: Nora Mohamed Abdelrazik • Aim: Symptom relief
Last updated May 13, 2026 16:04 UTC